The current landscape of standard of care and new drug development in HER2+ metastatic breast cancer

The current landscape of standard of care and new drug development in HER2+ metastatic breast cancer

E-session 505000 / NO CME
Add to My Agenda Remove from My Agenda

Expert:

Etcheverry Maria Graciela, expert of session 'The current landscape of standard of care and new drug development in HER2+ metastatic breast cancer'

Etcheverry Maria Graciela

Enter the recorded session

Share on:

18
Nov 2019
18:15-19:00 CET

Top